000 01402 a2200409 4500
005 20250513184212.0
264 0 _c19990803
008 199908s 0 0 eng d
022 _a0163-4356
024 7 _a10.1097/00007691-199906000-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBonfigli, A R
245 0 0 _aDetermination of plasma metformin by a new cation-exchange HPLC technique.
_h[electronic resource]
260 _bTherapeutic drug monitoring
_cJun 1999
300 _a330-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAged
650 0 4 _aChromatography, High Pressure Liquid
_xmethods
650 0 4 _aChromatography, Ion Exchange
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadverse effects
650 0 4 _aMale
650 0 4 _aMetformin
_xadverse effects
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
700 1 _aManfrini, S
700 1 _aGregorio, F
700 1 _aTesta, R
700 1 _aTesta, I
700 1 _aDe Sio, G
700 1 _aCoppa, G
773 0 _tTherapeutic drug monitoring
_gvol. 21
_gno. 3
_gp. 330-4
856 4 0 _uhttps://doi.org/10.1097/00007691-199906000-00015
_zAvailable from publisher's website
999 _c10324188
_d10324188